Transmigration of melanoma cells through the blood-brain barrier: Role of endothelial tight junctions and melanoma-released serine proteases

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Fazakas, Csilla ^a   Wilhelm, Imola ^a   Nagyoszi, Péter ^a   Farkas, Attila E ^a   Haskó, János ^a   Molnár, Judit ^a   Bauer, Hannelore ^b   Bauer, Hans Christian ^b   Ayaydin, Ferhan ^a   Dung, Ngo Thi Khue ^a   Siklós, László ^a   Krizbai, István A ^a  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b UNIVERSITY OF SALZBURG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

SEPRASE; SERINE PROTEINASE;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; BRAIN METASTASIS; CELL ADHESION; CELL CONTACT; CELL COUNT; CELL CULTURE; CELL DISRUPTION; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; MELANOMA CELL; NONHUMAN; RAT; TIGHT JUNCTION; ANIMAL; ENZYMOLOGY; METABOLISM; MOUSE; PATHOLOGY; SECRETION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR CELL LINE;

ANIMALS; BLOOD-BRAIN BARRIER; CELL LINE, TUMOR; ENDOTHELIAL CELLS; HUMANS; MELANOMA; MICE; RATS; SERINE PROTEASES; TIGHT JUNCTIONS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 79957976779     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020758     Document Type: Article

References (42)

1. Denkins Y, Reiland J, Roy M, Sinnappah-Kang ND, Galjour J, et al. (2004) Brain metastases in melanoma: roles of neurotrophins. Neuro Oncol 6: 154-165.
2. Sloan AE, Nock CJ, Einstein DB, (2009) Diagnosis and treatment of melanoma brain metastasis: a literature review. Cancer Control 16: 248-255.
3. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ, (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37: 13-25.
4. Bauer HC, Traweger A, Zweimueller-Mayer J, Lehner C, Tempfer H, et al. (2011) New aspects of the molecular constituents of tissue barriers. J Neural Transm 118: 7-21.
5. Qi J, Chen N, Wang J, Siu, CH, (2005) Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. Mol Biol Cell 16: 4386-4397.
6. Colone M, Calcabrini A, Toccacieli L, Bozzuto G, Stringaro A, et al. (2008) The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? J Invest Dermatol 128: 957-971.
7. Jung ID, Lee J, Yun SY, Park CG, Choi WS, et al. (2002) Cdc42 and Rac1 are necessary for autotaxin-induced tumor cell motility in A2058 melanoma cells. FEBS Lett 532: 351-356.
8. Sahai E, Marshall CJ, (2003) Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5: 711-719.
9. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, et al. (2008) Rac activation and inactivation control plasticity of tumor cell movement. Cell 135: 510-523.
10. Rolland Y, Demeule M, Fenart L, Béliveau R, (2009) Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface. Pigment Cell Melanoma Res 22: 86-98.
11. Perides G, Zhuge Y, Lin T, Stins MF, Bronson RT, Wu JK, (2006) The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis. BMC Cancer 6: 56.
12. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, et al. (2010) Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 16: 116-122.
13. Li B, Zhao WD, Tan ZM, Fang WG, Zhu L, Chen YH, (2006) Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett 580: 4252-4260.
14. Bezuhly M, Cullen R, Esmon CT, Morris SF, West KA, et al. (2009) Role of activated protein C and its receptor in inhibition of tumor metastasis. Blood 113: 3371-3374.
15. Carman CV, (2009) Mechanisms for transcellular diapedesis: probing and pathfinding by 'invadosome-like protrusions'. J Cell Sci 122: 3025-3035.
16. Dejana E, (2006) The transcellular railway: insights into leukocyte diapedesis. Nat Cell Biol 8: 105-107.
17. Chen D, Kennedy A, Wang JY, Zeng W, Zhao Q, et al. (2006) Activation of EDTA-resistant gelatinases in malignant human tumors. Cancer Res 66: 9977-9985.
18. Kügler S, Böcker K, Heusipp G, Greune L, Kim KS, Schmidt MA, (2007) Pertussis toxin transiently affects barrier integrity, organelle organization and transmigration of monocytes in a human brain microvascular endothelial cell barrier model. Cell Microbiol 9: 619-632.
19. Man S, Ubogu EE, Williams KA, Tucky B, Callahan MK, Ransohoff RM, (2008) Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration. Clin Dev Immunol 2008.
20. Cranmer LD, Trevor KT, Bandlamuri S, Hersh EM, (2005) Rodent models of brain metastasis in melanoma. Melanoma Res 15: 325-356.
21. Cruz-Munoz W, Man S, Xu P, Kerbel RS, (2008) Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer Res 68: 4500-4505.
22. Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19: 1872-1874.
23. Carl SM, Lindley DJ, Couraud PO, Weksler BB, Romero I, et al. (2010) ABC and SLC transporter expression and pot substrate characterization across the human CMEC/D3 blood-brain barrier cell line. Mol Pharm 7: 1057-1068.
24. Förster C, Burek M, Romero IA, Weksler B, Couraud PO, Drenckhahn D, (2008) Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier. J Physiol 586: 1937-1949.
25. Raz A, Hart IR, (1980) Murine melanoma: a model for intracranial metastasis. Br J Cancer 42: 331-341.
26. Bridle BW, Li J, Jiang S, Chang R, Lichty BD, et al. (2010) Immunotherapy can reject intracranial tumor cells without damaging the brain despite sharing the target antigen. J Immunol 184: 4269-4275.
27. Lu W, Bucana CD, Schroit AJ, (2007) Pathogenesis and vascular integrity of breast cancer brain metastasis. Int J Cancer 120: 1023-1026.
28. Strell C, Entschladen F, (2008) Extravasation of leukocytes in comparison to tumor cells. Cell Commun Signal 6: 10.
29. Reijerkerk A, Kooij G, van der Pol SM, Khazen S, Dijkstra CD, de Vries HE, (2006) Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J 20: 2550-2552.
30. Wolburg H, Wolburg-Buchholz K, Engelhardt B, (2005) Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact. Acta Neuropathol 109: 181-190.
31. Khuon S, Liang L, Dettman RW, Sporn PH, Wysolmerski RB, Chew TL, (2010) Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: a three-dimensional FRET study. J Cell Sci 123: 431-440.
32. Artym VV, Kindzelskii AL, Chen WT, Petty HR, (2002) Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton. Carcinogenesis 23: 1593-1601.
33. Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, et al. (1994) A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res 54: 5702-5710.
34. Piñeiro-Sánchez ML, Goldstein LA, Dodt J, Howard L, Yeh Y, et al. (1997) Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease. J Biol Chem 272: 7595-7601.
35. Hofmann UB, Westphal JR, Waas ET, Zendman AJ, Cornelissen IM, et al. (1999) Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer 81: 774-782.
36. Sounni NE, Baramova EN, Munaut C, Maquoi E, Frankenne F, et al. (2002) Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization. Int J Cancer 98: 23-28.
37. Tsung AJ, Kargiotis O, Chetty C, Lakka SS, Gujrati M, et al. (2008) Downregulation of matrix metalloproteinase-2 (MMP-2) utilizing adenovirus-mediated transfer of small interfering RNA (siRNA) in a novel spinal metastatic melanoma model. Int J Oncol 32: 557-564.
38. O'Brien P, O'Connor BF, (2008) Seprase: an overview of an important matrix serine protease. Biochim Biophys Acta 1784: 1130-1145.
39. Gilmore BF, Lynas JF, Scott CJ, McGoohan C, Martin L, Walker B, (2006) Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPalpha). Biochem Biophys Res Commun 346: 436-446.
40. Wesley UV, Albino AP, Tiwari S, Houghton AN, (1999) A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 190: 311-322.
41. Hutamekalin P, Farkas AE, Orbók A, Wilhelm I, Nagyoszi P, et al. (2008) Effect of nicotine and polyaromtic hydrocarbons on cerebral endothelial cells. Cell Biol Int 32: 198-209.
42. Wilhelm I, Farkas AE, Nagyoszi P, Váró G, Bálint Z, et al. (2007) Regulation of cerebral endothelial cell morphology by extracellular calcium. Phys Med Biol 52: 6261-6274.